<VariationArchive RecordType="classified" VariationID="1677234" VariationName="NC_000020.10:g.(35575208_35579838)_(35580247_?)del" VariationType="Deletion" Accession="VCV001677234" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-06-05" DateCreated="2022-04-23" MostRecentSubmission="2022-04-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1668866" VariationID="1677234">
      <GeneList>
        <Gene Symbol="SAMHD1" FullName="SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" GeneID="25939" HGNC_ID="HGNC:15925" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="36889773" stop="36951708" display_start="36889773" display_stop="36951708" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="35520226" stop="35580245" display_start="35520226" display_stop="35580245" Strand="-" />
          </Location>
          <OMIM>606754</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000020.10:g.(35575208_35579838)_(35580247_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" outerStart="35575208" innerStart="35579838" innerStop="35580247" display_start="35575208" display_stop="35580247" variantLength="5040" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.(35575208_35579838)_(35580247_?)del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.(35575208_35579838)_(35580247_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000020.10:g.(35575208_35579838)_(35580247_?)del AND Aicardi Goutieres syndrome" Accession="RCV002223092" Version="1">
        <ClassifiedConditionList TraitSetID="9630">
          <ClassifiedCondition DB="MedGen" ID="C0393591">Aicardi Goutieres syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-04-23" MostRecentSubmission="2022-04-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20653736</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21102625</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24183309</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9630" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9456" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi Goutieres syndrome</ElementValue>
                <XRef ID="230312006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, familial infantile, with calcification of basal ganglia and chronic cerebrospinal fluid lymphocytosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AGS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="575" />
                <XRef ID="575" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Gouti√®res syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C0393591" DB="MedGen" />
              <XRef ID="MONDO:0018866" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS225750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4891439" SubmissionDate="2022-04-19" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NC_000020.10:g.(35575208_35579838)_(35580247_?)del|MedGen:C0393591" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002500815" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24183309</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21102625</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20653736</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exon 1 that contains the canonical translation initiation codon of the SAMHD1 gene. A presumed nomenclature of c.(?_-201)_(208+1_209-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in an absent or shortened protein product, a known mechanism of disease. A large deletion that includes exon 1 of the SAMHD1 gene, and extends upstream from the gene about 6 kbp was found at a frequency of 9.2e-05 in 21694 control chromosomes (i.e. 2/21694 alleles in the gnomAD structural variants dataset). A variant, described as c.-6085_208+2691del (i.e. a ~9 kbp deletion) has been reported in the literature in multiple homozygous- and compound heterozygous individuals affected with Aicardi Goutieres Syndrome (e.g. Ramesh_2010, Leshinsky-Silver_2011, Rice_2013), and is considered an Ashkenazi Jewish founder mutation (Rice_2013). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. At least one clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SAMHD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.(35575208_35579838)_(35580247_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393591" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350627</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4891439" TraitType="Disease" MappingType="XRef" MappingValue="C0393591" MappingRef="MedGen">
        <MedGen CUI="C0393591" Name="Aicardi Goutieres syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

